Paul Poirier MD, PhD, FRCPC, FACC, FAHA, FCCSProfessor of Pharmacy, Laval University; Director, Cardiac Prevention/Rehabilitation Program, Institut Universitaire de Cardiologie et de Pneumologie de Québec, Quebec, Canada
Paul Poirier is a graduate of Laval University, Quebec, Canada. He received his bachelor degree in physical activity sciences and is master degree in experimental medicine studying the role of exercise training in Type 2 diabetes. He then went to medical school and obtained his MD degree in 1992 from Laval University where he subsequently completed specialty trainings in internal medicine and in cardiology from Laval University and also completed a PhD in experimental medicine studying the role of exercise in diabetes and the impact of diabetes on exercise capacity. He pursued post-doctoral studies at the University of Colorado Health Sciences Centre (Denver, Colorado) in the Endocrine division under the guidance of Dr. Robert H. Eckel. He is professor of the faculty of pharmacy at Laval University and is playing an important role in researcher training, teaching students and residents. Board certified cardiologist since twenty years, he was recruited in 2000 for medical leadership of the cardiac prevention/rehabilitation program at l’Institut universitaire de cardiologie et de pneumologie de Québec, Quebec (Canada). Dr. Poirier has several research interests and has collaborated on a wide variety of basic science and clinical studies, clinical trials on local, national and international scales. He is currently President of the Comité de promotion et prévention cardiovasculaire of the Association des Cardiologues du Québec (ACQ). Dr. Poirier is an author or coauthor of more than 500 scientific papers in peer reviewed journals, 450 abstracts, 35 chapter books and hundreds of presentations most of which are in the area of exercise, risk factors management, obesity, diabetes and cardiovascular disease. He has been chair of the Obesity Committee on the Council on Nutrition, Physical Activity and Metabolism of the American Heart Association. He was part of the macrovascular subcommittee of the Canadian Diabetes Association for the Clinical Practice Guidelines in Canada 2008, 2013 and 2018. He was involved in the recent Canadian lipid guidelines and in the recent Canadian obesity guidelines. He plays a very active role in grant and manuscript review. Dr. Poirier has a long-term interest in exercise, obesity, diabetes, cardiovascular risk factors s and cardiomyopathy and the role of weight loss and exercise in the management of these diseases.